The Recognition Award program has been established by the Association as a means of recognizing the commitment and achievement of individuals in the field of
Clinical Mass Spectrometry. This program is one of the means by which the Association encourages the advancement of mass spectrometry in clinical chemistry via the promotion
of research, education and application.
The MSACL Distinguished Contribution Award
In Recognition of Achievements Made
in the Field of Clinical Mass
Spectrometry that have Furthered
the Advancement of Knowledge
and the Implementation
of Science for the
Benefit of Humanity
Representative Award Medal
Composition: 0.925 silver
Self-nominations are not recognized for consideration.
The purpose of the Distinguished Contribution Award is to recognize a contributor who has conducted research, teaching or application of Mass Spectrometry in Clinical
Chemistry of significant impact.
Nominations will be evaluated on elements of the following criteria:
- Program of research: Quality, scope and overall impact on the profession,
- The extent to which the contribution is based on original concepts and/or innovative practices recognized throughout the field over a sustained period,
- The impact the contribution has had on the field, including education, influence on practitioners and the care of patients, organizations, thought leaders, and research,
- Influence on research advancement and career development within the profession
Nomination Application Information should include:
- The basic contact info of the nominee.
- A concise summary of the applicant's accomplishments and/or contributions.
- The basic contact info of the nominator.
The Award recognizes a focused or singular achievement in education, technology development or applied mass spectrometry in clinical chemistry. The award will be conferred at the MSACL US
2015 US: David Millington
Tandem Mass Spectrometry in Clinical Diagnostics, Newborn Screening and Targeted Metabolomics
2015 EU: Linda Thienpont
Mass Spectrometry as Metrological Anchor in Laboratory Medicine – a Meandering River
2016 US: Kenneth Setchell
What We Can Learn from a Drop of Urine – Metabolomics at It's Earliest: Discoveries of Bile Acid Synthesis Disorders, a New Category of Fatal Metabolic Liver Disease and
Development of a Treatment
2017 US: Catherine Feneslau
Rapid Characterization of Microorganisms by Mass Spectrometry: What can be Learned and How?
2017 EU: Isabelle Fournier
Laser-based Mass Spectrometry in Clinics: Changing the Paradigm of Molecular Diagnosis
2018 US: Richard Yost
The Triple Quadrupole: Innovation, Serendipity and Persistence
2018 EU: Cedric Shackleton
Mass Spectrometry and the Elucidation of Steroid Metabolome
2019 US: Donald Hunt
Immunotherapy of Cancer and the Role of Mass Spectrometry; An Overview and New Results
2019 EU: Zoltan Takats
15 years of Ambient Mass Spectrometry: From Amino Acid Clusters to Surgical Robotics
2020 US: Alan Rockwood
My Path to Enlightenment, or How I Became a Clinical Mass Spectrometrist and Clinical Chemist
2023: Jennifer Van Eyk
The Next Phase of Precision Medicine
The MSACL 2024 application deadline is September 16, 2023.
Award winner to receive notification by November 15, 2023 and to be be honored during the MSACL 2024 Conference in Monterey,